Yesterday, the I Medical Conference on Celiac Disease, organized by FACE (Federation of Celiac Associations of Spain), took place at the Hospital Clínico San Carlos in Madrid. These conferences were primarily aimed at specialized personnel, with the objective of providing knowledge about celiac disease, the latest scientific and medical advancements, as well as the perspective of patients.
Our CEO, Ángel Cebolla, attended the conference as a speaker, presenting on “Different Tools for Monitoring Celiac Disease: Symptoms from Gluten Consumption or Gluten Consumption without Symptoms?”. In his presentation, he discussed various methods for monitoring a gluten-free diet, highlighting the detection of gluten immunogenic peptides (GIP) in stool and urine. He also provided data regarding the correlation between asymptomatic and symptomatic individuals and compliance with a gluten-free diet.
The presentation concluded with a round of questions from the attendees.